Scinovex
article Open AccessTop 1% cited

The Cost of Epilepsy in the United States: An Estimate from Population‐Based Clinical and Survey Data

Epilepsia · 2000 · Vol. 41(3) · pp. 342–351
Charles E. BegleyMelissa FamulariJohn F. AnnegersDavid R. LairsonThomas F. ReynoldsSharon P. CoanStephanie DubinskyMichael NewmarkCynthia L. LeibsonE. L. SoWalter A. Rocca

Abstract

Direct costs attributable to epilepsy are below previous estimates. Indirect costs adjusted for the socioeconomic conditions of patients are above previous estimates. Findings indicate that epilepsy is unique in the large proportion of costs that are productivity-related, justifying further investment in the development of effective interventions.

Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesCystic Fibrosis Research AdvancesEpilepsyIndirect costsPopulationSocioeconomic statusComorbidityMedicineEarningsEconomic costTotal costDemography

MeSH terms

AdultAnticonvulsantsCosts and Cost AnalysisDirect Service CostsEpilepsyHealth SurveysHumansMathematicsMinnesotaRegression AnalysisSocioeconomic FactorsTexasUnited StatesComorbidityIncidence
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The Cost of Epilepsy in the United States: An Estimate from Population‐Based Clinical and Survey Data · Scinovex